⌘K
Loading ticker…
As of 2026-08-24, Imax Corp (IMAX) has a 3-month relative strength percentile of 91 and a leadership percentile of 97 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 68. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 4.0%, relative volume 0.98×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
IMAX is in a stage 2 uptrend, week 5. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 22.0% / 40.5%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
IMAX is held by 9 ETFs as of May 2026. Top owner: AVUV at 0.06% weight, $17M notional. Top 3 carry $22M.
Held by 12 ETFs · $24M across latest filings · largest weight 0.24% (MMSC).
Top 9 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| AVUVAvantis U.S. Small Cap Value ETF | 0.06% | $17M | −0.04 pp |
| AVSC | 0.15% | $4M | −0.04 pp |
| AVUSAvantis U.S. Equity ETF | 0.01% | $1M | — |
| GSSC | 0.06% | $577K | −0.01 pp |
| MMSC | 0.24% | $128K | new |
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY diluted average shares. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| AVSU |
| 0.02% |
| $71K |
| — |
| AVUQ | 0.03% | $70K | −0.01 pp |
| AVTM | 0.00% | $37K | — |
| EBI | 0.00% | $11K | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | IMAX Jan avg: -1.15% median: -6.27% win: 25% σ: 11.45% n: 4 2022-04-12 → 2026-07-31 | IMAX Feb avg: 15.62% median: 15.66% win: 100% σ: 8.12% n: 4 2022-04-12 → 2026-07-31 | IMAX Mar avg: -2.48% median: -1.34% win: 50% σ: 7.26% n: 4 2022-04-12 → 2026-07-31 | IMAX Apr avg: -1.02% median: -0.99% win: 40% σ: 6.57% n: 5 2022-04-12 → 2026-07-31 | IMAX May avg: 2.75% median: 4.37% win: 80% σ: 12.09% n: 5 2022-04-12 → 2026-07-31 | IMAX Jun avg: -0.33% median: 0.40% win: 60% σ: 1.88% n: 5 2022-04-12 → 2026-07-31 | IMAX Jul avg: 9.19% median: 8.36% win: 60% σ: 13.92% n: 5 2022-04-12 → 2026-07-31 | IMAX Aug avg: 2.09% median: 2.17% win: 75% σ: 7.27% n: 4 2022-04-12 → 2026-07-31 (current) | IMAX Sep avg: 0.63% median: -1.11% win: 50% σ: 10.39% n: 4 2022-04-12 → 2026-07-31 | IMAX Oct avg: 0.52% median: -3.27% win: 25% σ: 12.53% n: 4 2022-04-12 → 2026-07-31 | IMAX Nov avg: 10.69% median: 11.25% win: 75% σ: 18.57% n: 4 2022-04-12 → 2026-07-31 | IMAX Dec avg: -5.54% median: -4.28% win: 0% σ: 5.58% n: 4 2022-04-12 → 2026-07-31 |